Neurogene (NGNE) Interest Coverage Ratio (QoQ) (2013 - 2026)
Neurogene (NGNE) Interest Coverage Ratio (QoQ) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Neurogene |
216.17 Mn |
216.17 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-2,670.89% |
| Dec 31, 2025 |
125.44% |
| Sep 30, 2025 |
-60.77% |
| Jun 30, 2025 |
97.28% |
| Mar 31, 2025 |
-20.49% |
| Dec 31, 2024 |
-45.48% |
| Sep 30, 2024 |
-19,472.10% |
| Jun 30, 2024 |
99.40% |
| Mar 31, 2024 |
-622.29% |
| Dec 31, 2023 |
77.22% |
| Sep 30, 2023 |
9.38% |
| Jun 30, 2023 |
3.37% |
| Sep 30, 2015 |
-32.53% |
| Jun 30, 2015 |
11.11% |
| Mar 31, 2015 |
-205.47% |
| Dec 31, 2014 |
132.23% |
| Sep 30, 2014 |
-15.86% |
| Jun 30, 2014 |
-32,512.45% |
| Mar 31, 2014 |
91.06% |
| Dec 31, 2013 |
95.47% |
